MOLECULAR MECHANISMS REGULATING CD19, CD20 AND CD22 GENE-EXPRESSION

被引：71
|
作者：
KEHRL, JH
RIVA, A
WILSON, GL
THEVENIN, C
机构：
[1] John H. Kehrl, Agostino Riva, Gaye Lynn Wilson and Claire Thévenin are in the Section of B Cell Molecular Immunology, Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda
来源：
IMMUNOLOGY TODAY | 1994年 / 15卷 / 09期
关键词：
D O I：
10.1016/0167-5699(94)90273-9
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
The CD19, CD20 and CD22 genes encode transmembrane proteins that are of vital importance to B-cell function. Similar to the immunoglobulin (Ig) genes, they are expressed in a lineage-specific and developmentally regulated manner. Here, John Kehrl and colleagues describe how an understanding of the transcriptional regulation of the CD19, CD20 and CD22 genes is leading to valuable insights into some of the important molecular events that occur in B-cell development and differentiation.
引用
收藏
页码：432 / 436
页数：5
相关论文
共 50 条
  • [41] Evaluation of CD20, CD22, and HLA-DR targeting for radioimmunotherapy of B-cell lymphomas
    Pagel, John M.
    Pantelias, Anastasia
    Hedin, Nathan
    Wilbur, Shani
    Saganic, Laura
    Lin, Yukang
    Axworthy, Donald
    Hamlin, Donald K.
    Wilbur, D. Scott
    Gopal, Ajay K.
    Press, Oliver W.
    CANCER RESEARCH, 2007, 67 (12) : 5921 - 5928
  • [42] Comparison of CD20 and CD22 expression by human peripheral blood B cells, tonsilar cells and lymphoma cell lines.
    Kern, B
    Zhang, L
    Leal, J
    Carnahan, J
    Radinsky, R
    Molineux, G
    Briddell, R
    BLOOD, 2001, 98 (11) : 36B - 36B
  • [43] Canine CD20 gene
    Kano, R
    Inoiue, C
    Okano, H
    Yamazaki, J
    Takahashi, T
    Watari, T
    Tokuriki, M
    Hasegawa, A
    VETERINARY IMMUNOLOGY AND IMMUNOPATHOLOGY, 2005, 108 (3-4) : 265 - 268
  • [44] CD22 Expression in Childhood Leukemia
    Deguchi, Takao
    Kiyokawa, Nobutaka
    Ohki, Kentaro
    Manabe, Atsushi
    Saito, Akiko
    Horibe, Keizo
    PEDIATRIC BLOOD & CANCER, 2018, 65 : S63 - S63
  • [45] CD19/CD22 bispecific chimeric antigen receptor-NK-92 cells are developed and evaluated
    Kim, Hyori
    Han, Mina
    Kim, Minsong
    Kim, Hyeri
    Im, Ho Joon
    Kim, Nayoung
    Koh, Kyung-Nam
    ONCOLOGY LETTERS, 2023, 25 (06)
  • [46] CD19/CD22 Dual-Targeted CAR-TTherapy Active in Relapsed/Refractory DLBCL
    不详
    ONCOLOGIST, 2020, 25 : S12 - S13
  • [47] Non-structural determinants of immunogenicity and the B cell co-receptors, CD19, CD21, and CD22
    Fearon, DT
    MECHANISMS OF LYMPHOCYTE ACTIVATION AND IMMUNE REGULATION VII: MOLECULAR DETERMINANTS OF MICROBIAL IMMUNITY, 1998, 452 : 181 - 186
  • [48] 急性白血病细胞CD19和CD20表达比较(英文)
    宁铂涛
    汤永民
    陈英虎
    沈红强
    钱柏芹
    中国实验血液学杂志, 2005, (06) : 943 - 947
  • [49] Combating antigen escape with CD19/CD20 bispecific CAR-T cell therapy
    Zah, Eugenia
    Lin, Meng-Yin
    Jensen, Michael C.
    Silva-Benedict, Anne
    Chen, Yvonne Y.
    CANCER IMMUNOLOGY RESEARCH, 2017, 5 (03)
  • [50] Immunotherapy-resistant acute lymphoblastic leukemia cells exhibit reduced CD19 and CD22 expression and BTK pathway dependency
    Aminov, Sarah
    Giricz, Orsi
    Melnekoff, David T.
    Sica, R. Alejandro
    Polishchuk, Veronika
    Papazoglu, Cristian
    Yates, Bonnie
    Wang, Hao-Wei
    Sahu, Srabani
    Wang, Yanhua
    Gordon-Mitchell, Shanisha
    Leshchenko, Violetta V.
    Schinke, Carolina
    Pradhan, Kith
    Aluri, Srinivas
    Sohn, Moah
    Barta, Stefan K.
    Agarwal, Beamon
    Goldfinger, Mendel
    Mantzaris, Ioannis
    Shastri, Aditi
    Matsui, William
    Steidl, Ulrich
    Brody, Joshua D.
    Shah, Nirali N.
    Parekh, Samir
    Verma, Amit
    JOURNAL OF CLINICAL INVESTIGATION, 2024, 134 (08):
12345